Breast cancer burden in the United States (1990–2021) with a 15-year forecast: a comprehensive analysis based on the global burden of disease 2021
BC burden in the U.S. decreased overall, but disparities persist across sex, age groups, and states with varying SDI levels. Addressing risk factors and improving healthcare access are essential to further reduce BC burden.
Authors
- Xinghui Sun (ORCID: https://orcid.org/0000-0002-1156-0375)
- Peizhang Liu
- Peixin Zheng
- Lisheng Lin (ORCID: https://orcid.org/0000-0002-3673-8184)
- Hongxiang Lin
- Lingxiao Zhang (ORCID: https://orcid.org/0009-0009-0793-490X)
- Zhijian Huang (ORCID: https://orcid.org/0000-0003-4574-345X)
- Zihuan Peng
Institutions
- Northeastern University (US)
- Fujian Medical University (CN)
- Beth Israel Deaconess Medical Center (US)
- Massachusetts General Hospital (US)
- Fujian Provincial Cancer Hospital (CN)
- Putian University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-11-13
- DOI
- https://doi.org/10.3389/fonc.2025.1650110
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Gilead Sciences
- Beijing Xisike Clinical Oncology Research Foundation
- Natural Science Foundation of Fujian Province